Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Trials01:16

Clinical Trials

10.5K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.5K
Clinical Trials: Overview01:11

Clinical Trials: Overview

4.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.9K
Statistical Software for Data Analysis and Clinical Trials01:12

Statistical Software for Data Analysis and Clinical Trials

1.5K
Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
1.5K
Binary Fission01:26

Binary Fission

3.0K
Binary fission is the primary mode of asexual reproduction in prokaryotes, such as bacteria. It results in the production of two genetically identical daughter cells. This highly efficient process ensures the rapid propagation of bacterial populations under favorable conditions and involves coordinated cellular and molecular events.DNA Replication and SeparationThe process begins with the replication of the bacterial chromosome. The circular DNA molecule unwinds at a specific origin of...
3.0K
Binary Fission01:20

Binary Fission

63.5K
Fission is the division of a single entity into two or more parts, which regenerate into separate entities that resemble the original. Organisms in the Archaea and Bacteria domains reproduce using binary fission, in which a parent cell splits into two parts that can each grow to the size of the original parent cell. This asexual method of reproduction produces cells that are all genetically identical.
63.5K
Trial and Error and Algorithm01:12

Trial and Error and Algorithm

411
A problem-solving strategy is a plan of action used to find a solution. Different strategies have distinct action plans. Trial and error involves trying different solutions until one works. For instance, to fix a broken printer, you might check ink levels, ensure the paper tray isn't jammed, and verify the printer's connection to your laptop. This method can be time-consuming but is commonly used. Thomas Edison, for example, used trial and error to find a suitable filament for the light...
411

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Predicting median survival from early follow-up data: opportunities, limitations, and extensions.

Journal of the National Cancer Institute·2026
Same author

Generalized Pairwise Comparisons in Dose Optimization Oncology Trials: Beyond Safety to Multi-outcome Dose Selection.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

International Consensus-Driven Recommendations for Patient-Reported Outcome Research Objectives in Early Phase Dose-Finding Oncology Trials: OPTIMISE-ROR.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Nous-209 neoantigen vaccine for cancer prevention in Lynch syndrome carriers: a phase 1b/2 trial.

Nature medicine·2026
Same author

Investigation of Profile-Related Evidence Determining Individualized Cancer Therapy (I-PREDICT) N-of-1 Precision Oncology Study: Molecular Profiling to Match Individually Dosed, Personalized Drug Combinations.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

MET Overexpression Is Associated with Superior Immunotherapy Benefit in Advanced Non-Small Cell Lung Cancer.

Cancers·2025

Related Experiment Video

Updated: Feb 1, 2026

In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

2.3K

Bayesian hierarchical classification and information sharing for clinical trials with subgroups and binary outcomes.

Nan Chen1, J Jack Lee1

  • 1Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Biometrical Journal. Biometrische Zeitschrift
|December 4, 2018
PubMed
Summary

This study introduces a new Bayesian model for clinical trials that classifies subgroups into clusters. This approach improves information sharing within clusters, reducing bias and enhancing efficiency in multigroup phase II trials.

Keywords:
classificationclinical trial designhierarchical modelinformation borrowingmultigroup phase II trialsubgroup analysis

More Related Videos

Heuristic Mining of Hierarchical Genotypes and Accessory Genome Loci in Bacterial Populations
08:03

Heuristic Mining of Hierarchical Genotypes and Accessory Genome Loci in Bacterial Populations

Published on: December 7, 2021

2.8K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

8.1K

Related Experiment Videos

Last Updated: Feb 1, 2026

In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

2.3K
Heuristic Mining of Hierarchical Genotypes and Accessory Genome Loci in Bacterial Populations
08:03

Heuristic Mining of Hierarchical Genotypes and Accessory Genome Loci in Bacterial Populations

Published on: December 7, 2021

2.8K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

8.1K

Area of Science:

  • Biostatistics
  • Clinical Trial Design
  • Statistical Modeling

Background:

  • Bayesian hierarchical models facilitate information sharing across subgroups in clinical trials.
  • Traditional models pool all subgroups, which can cause bias or inefficiency when subgroup differences are substantial.

Purpose of the Study:

  • To propose a novel hierarchical Bayesian classification and information sharing (BaCIS) model.
  • To address limitations of traditional models in multigroup phase II clinical trials with binary outcomes.

Main Methods:

  • Developed the BaCIS model, incorporating subgroup classification into hierarchical modeling.
  • Classified subgroups into two clusters based on outcomes, enabling cluster-specific information sharing.
  • Applied the model to the design and analysis of multigroup clinical trials.

Main Results:

  • The BaCIS model demonstrated improved operating characteristics compared to traditional hierarchical models.
  • Effective information sharing within identified clusters, mitigating bias and enhancing efficiency.
  • Robust performance across various simulated scenarios for binary outcomes.

Conclusions:

  • The BaCIS model offers a superior approach for designing and analyzing multigroup phase II clinical trials.
  • Subgroup classification within a Bayesian framework effectively balances information sharing and subgroup specificity.
  • This method enhances statistical power and reduces bias in trials with heterogeneous subgroups.